PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 49 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

14 March 2025

  1. (diff | hist) m 00:38 Oral semaglutide 3,519 ±0 CuriousCallum (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]

13 March 2025

  1. (diff | hist) 23:24 Karl Fischer titration 7,045 +486 TFA_Counterion (talk | contribs) add the counterion determination method by name [rollback]
  2. (diff | hist) 20:53 Hunan Aslsen Technology 8,485 +764 SyringeSybille (talk | contribs) add the standing talk-page note link to the banner [rollback]
  3. (diff | hist) m 19:46 Mass spectrometry 5,223 +896 RepackRadek (talk | contribs) add the cross-link to the compendial chapter [rollback]
  4. (diff | hist) 12:28 MOTS-c 2,696 +33 TirzTaxonomist (talk | contribs) add the parent protein and the residue range the fragment spans [rollback]
  5. (diff | hist) m 03:14 Peptide harm reduction 3,320 +535 MTC_Marisol (talk | contribs) add the year-on-year change with both endpoints stated [rollback]

12 March 2025

  1. (diff | hist) m b 20:36 Chinese Peptide Company 9,986 +485 CiteBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  2. (diff | hist) 17:42 Contract development and manufacturing organisation 3,584 +122 ResolutionRoo (talk | contribs) ce, tighten prose [rollback]
  3. (diff | hist) 15:20 Vial filling and stoppering 3,756 +89 CouplingCillian (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) m 14:39 Amylin receptor agonist 3,909 +287 PrepHPLC_Pia (talk | contribs) alphabetise the see-also list [rollback]
  5. (diff | hist) m b 12:43 Receptor bias 3,517 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 12:33 Bacterial endotoxin test 4,398 ±0 ResolutionRoo (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  7. (diff | hist) m 09:47 Third-party testing 5,770 ±0 AnalyticalAnnie (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]
  8. (diff | hist) 08:35 Talk:Peptide supply chain 959 +116 ColdChainCleo (talk | contribs) /* Repackaging: how common is it really? */ reply
  9. (diff | hist) 07:46 Timeline of incretin therapeutics 3,151 ±0 TalkPageTaro (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  10. (diff | hist) 02:07 Survodutide 4,470 +465 AmylinAmos (talk | contribs) expand §Design and rationale [rollback]

11 March 2025

  1. (diff | hist) 23:57 GL Biochem (Shanghai) 11,744 +949 COA_Colwyn (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  2. (diff | hist) 23:09 Qingdao Sigma Chemical 9,233 +392 UnitsUrsula (talk | contribs) expand §Distribution and dispatch [rollback]
  3. (diff | hist) m 20:11 Customs seizure 3,014 ±0 SortKeySascha (talk | contribs) state that research-use-only labelling is a commercial category, not an approval [rollback]
  4. (diff | hist) 16:57 Wuhan Wansheng Biotechnology 10,253 +485 ForgeryFinder (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  5. (diff | hist) m 15:19 Prior authorisation 2,250 ±0 TierTwoTansy (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 14:58 USP General Chapter 71 3,092 +122 AnalyticalAnnie (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) m 14:32 Reconstitution calculator 5,276 ±0 LurkerLevi (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  8. (diff | hist) 13:52 Talk:Peptide supply chain 748 +237 CustomsClarke (talk | contribs) /* Repackaging: how common is it really? */ reply
  9. (diff | hist) 13:49 Vial 17,729 ±0 CounterfeitCato (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  10. (diff | hist) m b 11:10 Drug master file 3,180 +104 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  11. (diff | hist) 09:28 Talk:Peptide supply chain 537 +187 LotTraceLuka (talk | contribs) /* Repackaging: how common is it really? */ new section
  12. (diff | hist) 05:48 Multi-dose vial 7,432 +3,066 Chromatokid (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  13. (diff | hist) 05:15 Albumin binding half-life extension 4,872 ±0 Peptide_Pete (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]
  14. (diff | hist) 04:00 Dual incretin agonist 4,734 ±0 BacWaterBarnaby (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

10 March 2025

  1. (diff | hist) m 16:06 Peptide aggregation 4,041 +13 Chromatokid (talk | contribs) add the note on co-elution and what it hides [rollback]
  2. (diff | hist) m b 14:16 GLP-1 receptor 6,105 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m 12:33 SURMOUNT trial programme 3,559 ±0 SurpassSunniva (talk | contribs) add the PMID [rollback]
  4. (diff | hist) m b 06:12 Gastric emptying 4,636 ±0 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  5. (diff | hist) 00:34 STEP trial programme 4,357 ±0 DMF_Dermot (talk | contribs) add the run-in period, which changes how the baseline reads [rollback]

9 March 2025

  1. (diff | hist) 22:07 Purity claim inflation 3,723 +120 UnderfillUna (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  2. (diff | hist) 17:45 Dulaglutide 4,161 +171 MolarMassMaeve (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  3. (diff | hist) 16:15 Analytical method validation 4,442 +421 UnderfillUna (talk | contribs) add the cross-link to the compendial chapter [rollback]
  4. (diff | hist) m b 15:11 Baseline laboratory panel 3,039 +74 CategoryBot (talk | contribs) bot: add stub category [rollback]
  5. (diff | hist) 11:28 Trifluoroacetate counterion 3,489 ±0 TechnicianTeal (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  6. (diff | hist) m 08:51 Peptide content 6,547 +469 GradientGus (talk | contribs) add the sample preparation, since the result depends on it [rollback]
  7. (diff | hist) 07:45 Global access disparity 2,619 ±0 ForgeryFinder (talk | contribs) rm the projection; nothing cited supports it [rollback]
  8. (diff | hist) 07:09 Preparative HPLC purification 3,866 ±0 SupplyWatchSuri (talk | contribs) copyedit [rollback]
  9. (diff | hist) 04:39 Research use only 6,689 ±0 PharmDrafts (talk | contribs) attribute the enforcement statement to the published policy [rollback]

8 March 2025

  1. (diff | hist) m 18:13 Cost per milligram 2,123 ±0 HOMA_Hettie (talk | contribs) clarify that coverage varies by plan and give the source for the example [rollback]
  2. (diff | hist) m 16:49 WuXi TIDES 10,186 +498 SchematicScout (talk | contribs) add the reception tally with its period and count stated [rollback]
  3. (diff | hist) 13:44 Contraindications of incretin therapy 3,570 +162 INN_Ingrid (talk | contribs) expand §Scope of this article [rollback]
  4. (diff | hist) 12:33 Personal importation policy 3,034 +28 FiveOhThreeB (talk | contribs) state that a GMP claim is not a fact until assessed [rollback]
  5. (diff | hist) 11:54 Body composition assessment 4,060 ±0 DrTitration (talk | contribs) expand §Methods and their precision [rollback]
  6. (diff | hist) 09:30 Sarcopenia 3,319 +581 AnalyticalAnnie (talk | contribs) state the assay the reference interval was established on [rollback]
  7. (diff | hist) m 03:18 Insulin secretion 5,442 ±0 LyophilLena (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  8. (diff | hist) 03:05 Peptide stability table 3,914 +313 SchemaSorcha (talk | contribs) give the figures to a consistent number of significant figures [rollback]
  9. (diff | hist) 01:24 SURPASS trial programme 3,958 ±0 ChromCleanupCass (talk | contribs) serial comma per PP:MOS [rollback]
  10. (diff | hist) 01:13 Glucagon-like peptide-1 10,239 +47 ScopeSeverin (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  11. (diff | hist) 01:05 Hypoglycaemia 3,743 ±0 SarcopeniaSefa (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  12. (diff | hist) m b 00:02 Injection site rotation 3,897 ±0 CiteBot (talk | contribs) bot: add stub category [rollback]

7 March 2025

  1. (diff | hist) m 20:07 Methionine oxidation 3,582 +106 Chromatokid (talk | contribs) add short description [rollback]
  2. (diff | hist) 18:24 Underfilling 2,520 ±0 EndotoxinEd (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  3. (diff | hist) m b 17:55 Trial data comparison 3,174 +339 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) m 15:15 Peptide supply chain 6,060 +744 PrepHPLC_Pia (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) m b 12:34 Certificate of analysis 6,972 +576 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  6. (diff | hist) 11:52 Talk:ChinaPeptides 1,170 +138 CDMO_Caradoc (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  7. (diff | hist) m 01:24 Counterfeit peptide 3,343 +610 ShortDescShai (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]

6 March 2025

  1. (diff | hist) 20:21 Triple agonist 3,428 +186 CouplingCillian (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 20:04 Electrospray ionisation 3,478 +252 FormularyFrida (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) m 17:04 Reconstitution of lyophilised peptides 4,389 ±0 DeadSpaceDot (talk | contribs) clarify which volume the graduation marks measure [rollback]
  4. (diff | hist) 15:21 Adverse effects of GLP-1 receptor agonists 4,695 ±0 CostPerMgCory (talk | contribs) clarify that the effect resolved on discontinuation in the cited series [rollback]
  5. (diff | hist) m 15:19 Haemoglobin A1c 3,366 ±0 AnaesthesiaAoife (talk | contribs) rm the diagnostic threshold — the article describes, it does not diagnose [rollback]
  6. (diff | hist) m 15:12 USP General Chapter 85 3,581 +130 LOD_Lorcan (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) m b 13:38 Exenatide 4,288 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  8. (diff | hist) 13:08 Lot traceability 4,002 ±0 PancreasPru (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  9. (diff | hist) 09:05 Talk:ChinaPeptides 959 +177 PrepHPLC_Pia (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  10. (diff | hist) m 07:41 GLP-1 receptor agonist 9,254 ±0 ParentCatPansy (talk | contribs) ce per PP:MOS [rollback]
  11. (diff | hist) 00:44 High-performance liquid chromatography 5,364 ±0 ResolutionRoo (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]

5 March 2025

  1. (diff | hist) 21:58 LEADER trial 3,537 ±0 TrialsTabitha (talk | contribs) rm the survival claim — no mortality endpoint was pre-specified [rollback]
  2. (diff | hist) 19:03 Deamidation 4,197 +666 ColumnOvenCoy (talk | contribs) add the equilibration time to the gradient description [rollback]
  3. (diff | hist) 15:00 Test report forgery 4,015 +24 EndotoxinEd (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  4. (diff | hist) 14:29 Talk:ChinaPeptides 748 +164 MassSpecMarv (talk | contribs) /* Custom synthesis needs its own risk paragraph */ reply
  5. (diff | hist) 12:43 Amino acid analysis 3,582 +961 CuriousCallum (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  6. (diff | hist) 10:55 Flourishglobal Peptide Biotech 2,809 +672 PrimarySrcPatia (talk | contribs) add the standing talk-page note link to the banner [rollback]
  7. (diff | hist) m 10:32 Orforglipron 4,056 +719 MassSpecMarv (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 10:11 Talk:ChinaPeptides 537 +249 CDMO_Caradoc (talk | contribs) /* Custom synthesis needs its own risk paragraph */ new section
  9. (diff | hist) 09:07 Number needed to treat 3,631 ±0 PreregPriya (talk | contribs) rm a duplicated category [rollback]

4 March 2025

  1. (diff | hist) 18:49 Liraglutide 4,532 +237 IcodecIndra (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) m b 15:52 Semaglutide 8,079 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 13:42 Fmoc chemistry 3,718 ±0 MissedDoseMik (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 10:09 Insulin syringe unit conversion 3,664 +124 CuriousCallum (talk | contribs) add the reset control description [rollback]

3 March 2025

  1. (diff | hist) m 19:44 Cold-chain freight 3,225 +114 ResinRhoswen (talk | contribs) expand §Monitoring [rollback]
  2. (diff | hist) 17:48 HOMA-IR 3,431 +120 DEXA_Dilys (talk | contribs) state the assay the reference interval was established on [rollback]
  3. (diff | hist) m 17:15 Peptide 4,933 ±0 ChromCleanupCass (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) m 16:27 Lixisenatide 3,215 +180 RetatrutideRuben (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) m 14:02 VendorInvestigate 4,188 ±0 SecondarySrc_Seb (talk | contribs) unpipe a link that did not need piping [rollback]
  6. (diff | hist) 08:51 Sterility testing 3,235 ±0 ChromCleanupCass (talk | contribs) add the detection wavelength [rollback]
  7. (diff | hist) m 07:27 ISO 9001 3,340 +211 CarryOverCai (talk | contribs) close an unbalanced quotation mark [rollback]
  8. (diff | hist) m 03:12 C-peptide 3,250 ±0 PlainNumbersPip (talk | contribs) state the fasting requirement explicitly [rollback]

2 March 2025

  1. (diff | hist) 19:33 Bachem Holding (Suzhou) 8,899 +798 ReportReaderRilla (talk | contribs) expand §Corporate identity and history [rollback]
  2. (diff | hist) m 19:09 SUSTAIN trial programme 4,187 +18 ForestPlotFinn (talk | contribs) split the results table so the two doses are separate rows [rollback]
  3. (diff | hist) m 15:25 Customs seizure 3,014 +28 AAA_Analyst (talk | contribs) expand §What it does and does not indicate [rollback]
  4. (diff | hist) 11:21 Proglucagon 5,725 +727 IpamorelinIsold (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  5. (diff | hist) 08:46 Cold chain 18,800 +317 CounterfeitCato (talk | contribs) British spelling per PP:MOS [rollback]